AstraZeneca bullish pennant
Updated
There hasn't been a significant rise in Astrazeneca, despite the approval of the vaccine in the UK, the orders from Indonesia and Taiwan and reassuring news about the effectiveness of the vaccine. I think some negative publicity about the vaccine effectiveness in comparison to the other vaccines in the US could have led to this consolidation, but even if the other vaccines are a few percents more efficient, the cost and storage efficiency will be a large differentiator for many countries. The approval of the UK will give confidence to other countries (India, Brazil, Europe,...) to speed up the approval process, I expect this will cause the stock to break upwards after more countries approve it.
Note
Astrazeneca broke out today, looking bullish
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.